Prevalence worldwide
Oropharyngeal cancer is a common head and neck malignancy worldwide, with higher incidence in developed countries in Europe and North America. Men significantly outnumber women.
Oropharyngeal cancer treatment by stage
Early-stage treatment (localized tumor, tumor shrinkage, good response)
Surgical removal combined with adjuvant radiotherapy effectively controls tumor progression while preserving swallowing and speech.
Intermediate-stage treatment (local spread, growth inhibition, delayed progression)
Surgery combined with chemoradiotherapy and other modalities controls spread to cervical lymph nodes and slows disease progression.
Advanced-stage treatment (distant metastasis, symptom relief, prolonged survival)
Systemic treatments such as chemoradiotherapy and targeted therapy relieve symptoms including swallowing difficulty and extend survival as much as possible.
Consequences of failing to receive timely treatment in the early stage: If standardized treatment is not administered promptly in the early stage, the tumor will continue to grow and spread/metastasize to surrounding tissues and distant organs, resulting in a missed opportunity for optimal intervention and a worsening of the condition.
Why choose Fosun Health for oropharyngeal cancer treatment
Fosun Health draws on its hospitals' M6 CyberKnife, VitalBeam, and transoral minimally invasive and head and neck surgery platforms for multidisciplinary consultations involving head and neck surgery, radiotherapy, imaging, pathology, medical oncology, and rehabilitation specialists. The team selects transoral surgery, organ-preserving chemoradiotherapy, or systemic treatment according to tumor stage, p16/HPV status, cervical lymph nodes, and physical condition.
Precision radiotherapy covers primary lesions in the tonsils and tongue base and high-risk neck regions while minimizing exposure of the parotid glands, mandible, oral cavity, larynx, and pharyngeal constrictors to reduce some risks of dry mouth, aspiration, and long-term swallowing impairment. Fosun Health also integrates dental treatment, oral care, nutrition, speech, and swallowing training throughout care.
Oropharyngeal cancer treatment methods
1.M6 CyberKnife treatment
Real-time imaging verification and focused radiation from multiple angles are suitable for MDT-assessed small residual, recurrent, or oligometastatic oropharyngeal cancer lesions.
Treatment advantages:
①Focuses on localized lesions: Suitable for selected recurrent or residual lesions with clear boundaries.
②Protects swallowing structures: Reduces doses to the pharyngeal constrictors, larynx, and oral cavity.
③Protects neck organs: Reduces doses to the carotid arteries, spinal cord, and mandible.
④Careful reirradiation assessment: Focuses on preventing mucosal necrosis and carotid bleeding.
2.VitalBeam precision radiotherapy
Image-guided and intensity-modulated radiotherapy treats primary lesions in the tonsils and tongue base and cervical lymphatic regions, suitable for definitive, postoperative adjuvant, or palliative radiotherapy.
Treatment advantages:
①Covers complex targets: Includes primary lesions and retropharyngeal and cervical lymph nodes.
②Protects salivary glands: Reduces parotid doses and long-term dry mouth.
③Preserves swallowing: Reduces doses to the oral cavity, larynx, and pharyngeal constrictors.
④Facilitates combined treatment: Can be coordinated with concurrent chemotherapy or transoral surgery.
3.Transoral minimally invasive resection and cervical lymph node management
Suitable for early or selected locally advanced oropharyngeal cancers in favorable locations where safe margins can be achieved.
4.Chemotherapy
Anticancer drugs systemically eliminate potential cancer cells and effectively control tumor progression, commonly for intermediate and advanced oropharyngeal cancer.
5.Immunotherapy
Activating the immune system to recognize and attack cancer cells offers a new effective treatment option for advanced oropharyngeal cancer.
6.Seed implantation:
Suitable as a selective local treatment for patients with residual or recurrent oropharyngeal cancer, limited options due to prior radiotherapy, and clearly defined lesion extent after multidisciplinary evaluation.
Follow-up care after treatment
Maintain oral cleanliness and food hygiene, avoid spicy and irritating foods, attend regular follow-up appointments as instructed, and actively cooperate with subsequent treatment.
Post-treatment examinations
Regular laryngoscopy, tumor marker testing, and follow-up imaging are needed to detect changes in the condition promptly.
Conclusion
Oropharyngeal cancer is a serious disease. Early detection, diagnosis, and intervention are central to treatment. An appropriate treatment plan and continued follow-up help improve quality of life and prolong survival.
